NOVEL DAPTOMYCIN-PRODUCING STREPTOMYCES STRAIN AND USE THEREOF
20230118242 · 2023-04-20
Inventors
- Yongquan LI (Hangzhou City, Zhejiang Province, CN)
- Jiaole FANG (Hangzhou City, Zhejiang Province, CN)
- Xuming MAO (Hangzhou City, Zhejiang Province, CN)
- Xinai CHEN (Hangzhou City, Zhejiang Province, CN)
Cpc classification
C12P21/02
CHEMISTRY; METALLURGY
International classification
Abstract
The present invention provides a novel daptomycin-producing Streptomyces strain and use thereof, the strain is a subspecies of streptomyces griseus, named Streptomyces griseus L340, and the preservation number is CGMCC17921. The genetic character and fermentation unit of the strain provided by the present invention are relatively stable, the culture and fermentation conditions are suitable for industrial production of daptomycin, and the interference of pigment in later separation and purification is eliminated. The secondary metabolite daptomycin is obtained through fermentation of the Streptomyces provided by the present invention, which has the advantages of no interference of pigment accumulation, cleaner metabolic spectrum and thus is obviously superior in later separation and purification.
Claims
1. A novel daptomycin-producing Streptomyces strain, wherein the Streptomyces strain is classified and named as Streptomyces griseus L340 preserved in China General Microbiological Culture Collection Center with a preservation date of Jun. 12, 2019 and a preservation number of CGMCC17921.
2. A method for culturing the Streptomyces strain according to claim 1, comprising the following steps: (1) solid culture: inoculating the strain on an agarslantculture-medium, and culturing in an incubator at 30° C. for 5-8 days; and (2) liquid culture: inoculating the strain into a seed broth, culturing on a shaker with a rotation speed of 250 rpm at 30° C. for 36 hours, then inoculating a transfer amount of 4% into a fermentation medium, and culturing on a shaker with a rotation speed of 250 rpm at 30° C. for 4-6 days.
3. The method according to claim 2, wherein the agarslantculture-medium in the step (1) is a R5 medium, each liter of medium which contains 103 g of sucrose, 10 g of glucose, 5 g of yeast extract, 0.1 g of casein hydrolysate, 0.25 g of K.sub.2SO.sub.4, 10.12 g of MgCl.sub.2.6H.sub.2O, 2 mL of a trace element solution, 5.73 g of TES buffer, and 0.3 g of proline, which are diluted by water to a volume of 1 L, and 22 g of agar is added to a solid medium; in the step (2), the seed broth is a Trypticase Soy Broth medium: TSB 2%, PEG 6000 5%, which are diluted by water to a volume of 1 L, wherein the percentages are percentages by mass; and the fermentation medium in the step (2) is a yeast malt medium: 0.3% yeast extract, 0.3% malt extract, 0.5% tryptone, and 4% glucose, which are diluted to a volume of 1 L.
4. Use of the Streptomyces strain according to claim 1 in production of daptomycin.
5. The use according to claim 4, comprising the following steps: (1) cutting spores from an agarslantculture-medium, inoculating the spores into a seed broth, and culturing on a shaker with a rotation speed of 250 rpm at 30° C. for 36 hours until a bacterial liquid is sticky and granular; (2) harvesting 4% by volume of the bacterial liquid from the seed broth, inoculating into the fermentation medium, and culturing on a shaker with a rotation speed of 250 rpm at 30° C.; and after 48 hours, feeding decanoic acid in 0.1% by volume of the fermentation medium every 12 hours; (3) after 144 hours, treating the fermentation medium with methanol of equal volume, and subjecting a supernatant obtained after centrifugation to subsequent separation and purification.
6. The use according to claim 5, wherein, definitions of the agarslantculture-medium, the seed broth and the fermentation medium are the same as in claim 3.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0025]
[0026]
[0027]
[0028]
[0029]
DESCRIPTION OF EMBODIMENTS
[0030] The present invention will be further explained with reference to drawings and examples.
[0031] The experimental methods in the following examples are all conventional methods, unless otherwise specified.
[0032] The medium used in the examples:
[0033] A slant R5 agar medium: each liter of the medium contains 103 g of sucrose, 10 g of glucose, 5 g of yeast extract, 0.1 g of casein hydrolysate, 0.25 g of K.sub.2SO.sub.4, 10.12 g of MgCl.sub.2.6H.sub.2O, 2 mL of a trace element solution, 5.73 g of TES buffer, 0.3 g of L-proline, which are diluted by water to a volume of 1 L (22 g of agar is added to a solid medium), which is sterilized at 115° C. for 25 min. After sterilization, the following solutions are added in turn: 10 mL of 5% KH.sub.2PO.sub.4, 4 mL of 5M CaCl.sub.2.2H.sub.2O, 700 μL of 10M NaOH, which are shaken well, poured onto the plate and solidified for later use. A trace element storage solution: 40 mg of ZnCl.sub.2, 200 mg of FeCl.sub.3.6H.sub.2O, 10 mg of CuCl.sub.2.2H.sub.2O, 10 mg of MnCl.4H.sub.2O, 10 mg of Na.sub.2B.sub.4O.sub.7.10H.sub.2O and 10 mg of (NH.sub.4) Mo.sub.7O.sub.24.4H.sub.2O, to which water is added to a volume of 1 L for later use.
[0034] A seed broth (TSB): TSB 2%, PEG 6000 5%, which are diluted by water to a volume of 1 L; wherein, the percentages are by mass. The medium is sterilized at 115° C. for 25 min for later use.
[0035] A fermentation medium (YEME): 0.3% yeast extract, 0.3% malt extract, 0.5% tryptone, and 4% glucose, which are diluted by water to a volume of 1 L; wherein, the percentages are by mass. The medium is sterilized at 115° C. for 25 min for later use.
EXAMPLE 1
[0036] The present invention provides a novel daptomycin-producing Streptomyces strain. Compare with the traditional daptomycin-producing bacteria Streptomyces roseosporus, the novel daptomycin-producing strain provided by the invention has the great advantage that pigment substances are not produced in the process of subculture and fermentation, thereby reducing the difficulty for subsequent separation and purification operations. The strain provided by the present invention is preserved in China General Microbiological Culture Collection Center with the preservation date of Jun. 12, 2019, and the preservation number of CGMCC17921.
[0037] The apparent characteristics in different media are shown in Table 1, in which the colony morphology on a R5 medium is shown in
[0038] Compared with other 17 Streptomyces strains (see
TABLE-US-00001 TABLE 1 Cultural characteristics of strains: Color of the back Soluble Aerial side of the Medium pigment mycelium medium YEME none white yellowish ISP4 none white yellowish MM grey white white R5 none white yellowish
TABLE-US-00002 TABLE 2 Physiological and biochemical characteristics of strains: Characteristics Results pH range for growth pH < 4 − pH = 5-11 + pH = 12 W NaCl tolerance 3% NaCl + 5% NaCl W 7% NaCl − Growth temperature 30° C. + 37° C. − Melanin production − Milk coagulation + Starch hydrolysis + Gelatin liquefaction + Used carbon source D-glucose + D-fructose + Maltose + Sucrose + Glycerol + Inositol + D-mannitol + L-arabinose − D-xylose − L-rhamnose − Sodium acetate − Raffinose − Sorbitol − Note: “W” indicates a weak positive result, “+” indicates a positive result and “−” indicates a negative result
EXAMPLE 2
[0039] The method for culturing the daptomycin-producing Streptomyces strain is as below:
[0040] (1) solid culture: inoculating the strain on a agarslantculture-medium, and culturing the strain in an incubator at 30° C. for 5-8 days;
[0041] (2) liquid culture: inoculating the strain into a seed broth, culturing the strain on a shaker with a rotation speed of 250 rpm at 30° C. for 36 hours, then inoculating the strain into a fermentation medium based on a transfer amount of 4%, and culturing the strain on a shaker with a rotation speed of 250 rpm at 30° C. for 4-6 days; feeding 0.1% by volume of decanoic acid every 12 hours after 48 hours.
EXAMPLE 3
[0042] Shake flask fermentation was carried out according to Example 2, and samples were taken after 144 h hours. The color of the bacterial liquid at this time is shown in
[0043] The HPLC detection method is: HPLC chromatographic column: XDB-C18
[0044] Phase A: H.sub.2O+0.05% formic acid; phase B: acetonitrile +0.05% formic acid; Gradient of phase B is 5%-100%, 35 min.
[0045] The absorption peak of daptomycin can be seen at 21 min.